Mirum Pharmaceuticals Inc (MIRM)
43.48
-0.21
(-0.48%)
USD |
NASDAQ |
Nov 21, 16:00
43.48
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Shareholders Equity (Quarterly): 232.02M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 232.02M |
| June 30, 2024 | 228.99M |
| March 31, 2024 | 234.60M |
| December 31, 2023 | 248.67M |
| September 30, 2023 | 269.08M |
| June 30, 2023 | 78.61M |
| March 31, 2023 | 141.15M |
| December 31, 2022 | 142.04M |
| September 30, 2022 | 169.30M |
| June 30, 2022 | 110.69M |
| March 31, 2022 | 108.93M |
| December 31, 2021 | 120.21M |
| Date | Value |
|---|---|
| September 30, 2021 | 56.40M |
| June 30, 2021 | 95.74M |
| March 31, 2021 | 133.88M |
| December 31, 2020 | 172.10M |
| September 30, 2020 | 120.26M |
| June 30, 2020 | 136.21M |
| March 31, 2020 | 156.12M |
| December 31, 2019 | 130.35M |
| September 30, 2019 | 146.20M |
| June 30, 2019 | -27.95M |
| March 31, 2019 | -16.06M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
56.40M
Minimum
Sep 2021
269.08M
Maximum
Sep 2023
154.27M
Average
138.68M
Median
Shareholders Equity (Quarterly) Benchmarks
| Arcutis Biotherapeutics Inc | 156.64M |
| Cytokinetics Inc | -13.91M |
| Amicus Therapeutics Inc | 178.82M |
| MannKind Corp | -209.93M |
| TG Therapeutics Inc | 192.16M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 667.89M |
| Total Liabilities (Quarterly) | 435.87M |
| Debt to Equity Ratio | 1.326 |
| Current Ratio | 3.340 |
| Net Debt Paydown Yield | -0.02% |